| 3.1 |
9.2 |
GO:0050925 |
negative regulation of negative chemotaxis(GO:0050925) |
| 2.9 |
14.5 |
GO:0021965 |
spinal cord ventral commissure morphogenesis(GO:0021965) |
| 1.6 |
4.8 |
GO:0001869 |
regulation of complement activation, lectin pathway(GO:0001868) negative regulation of complement activation, lectin pathway(GO:0001869) |
| 1.5 |
4.5 |
GO:0016191 |
synaptic vesicle uncoating(GO:0016191) regulation of endosome organization(GO:1904978) positive regulation of endosome organization(GO:1904980) |
| 1.5 |
7.4 |
GO:1901843 |
positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
| 1.5 |
4.4 |
GO:0002302 |
CD8-positive, alpha-beta T cell differentiation involved in immune response(GO:0002302) |
| 1.3 |
4.0 |
GO:0032915 |
positive regulation of transforming growth factor beta2 production(GO:0032915) |
| 1.2 |
4.7 |
GO:0033326 |
cerebrospinal fluid secretion(GO:0033326) |
| 1.2 |
6.9 |
GO:0048934 |
peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
| 1.1 |
4.5 |
GO:0051643 |
endoplasmic reticulum localization(GO:0051643) |
| 1.0 |
2.1 |
GO:0002069 |
columnar/cuboidal epithelial cell maturation(GO:0002069) |
| 1.0 |
1.0 |
GO:0007096 |
regulation of exit from mitosis(GO:0007096) positive regulation of exit from mitosis(GO:0031536) |
| 1.0 |
3.1 |
GO:0060489 |
establishment of body hair or bristle planar orientation(GO:0048104) establishment of body hair planar orientation(GO:0048105) orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060488) planar dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060489) lateral sprouting involved in lung morphogenesis(GO:0060490) |
| 1.0 |
3.9 |
GO:2000795 |
negative regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000795) |
| 0.9 |
0.9 |
GO:0070094 |
positive regulation of glucagon secretion(GO:0070094) |
| 0.9 |
0.9 |
GO:0003219 |
cardiac right ventricle formation(GO:0003219) |
| 0.9 |
3.5 |
GO:0090283 |
regulation of protein glycosylation in Golgi(GO:0090283) |
| 0.9 |
2.6 |
GO:1903244 |
positive regulation of cardiac muscle adaptation(GO:0010615) positive regulation of cardiac muscle hypertrophy in response to stress(GO:1903244) |
| 0.8 |
3.3 |
GO:2000211 |
regulation of glutamate metabolic process(GO:2000211) |
| 0.8 |
2.4 |
GO:0042998 |
positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
| 0.8 |
2.4 |
GO:0060399 |
positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
| 0.8 |
3.1 |
GO:0010637 |
negative regulation of mitochondrial fusion(GO:0010637) |
| 0.8 |
0.8 |
GO:0097623 |
potassium ion export across plasma membrane(GO:0097623) |
| 0.8 |
4.7 |
GO:1901524 |
regulation of macromitophagy(GO:1901524) negative regulation of macromitophagy(GO:1901525) |
| 0.8 |
12.1 |
GO:0060081 |
membrane hyperpolarization(GO:0060081) |
| 0.8 |
2.3 |
GO:0031622 |
positive regulation of fever generation(GO:0031622) |
| 0.7 |
2.2 |
GO:0071873 |
response to norepinephrine(GO:0071873) |
| 0.7 |
1.5 |
GO:1901668 |
regulation of superoxide dismutase activity(GO:1901668) |
| 0.7 |
3.6 |
GO:0021699 |
cerebellar cortex maturation(GO:0021699) |
| 0.7 |
1.4 |
GO:0045763 |
negative regulation of cellular amino acid metabolic process(GO:0045763) regulation of cellular amino acid biosynthetic process(GO:2000282) |
| 0.7 |
2.1 |
GO:0006404 |
RNA import into nucleus(GO:0006404) |
| 0.7 |
5.4 |
GO:0034720 |
histone H3-K4 demethylation(GO:0034720) |
| 0.7 |
2.0 |
GO:0002331 |
pre-B cell allelic exclusion(GO:0002331) signal transduction involved in G2 DNA damage checkpoint(GO:0072425) signal transduction involved in mitotic G2 DNA damage checkpoint(GO:0072434) telomerase catalytic core complex assembly(GO:1904868) regulation of telomerase catalytic core complex assembly(GO:1904882) positive regulation of telomerase catalytic core complex assembly(GO:1904884) |
| 0.7 |
3.3 |
GO:0002182 |
cytoplasmic translational elongation(GO:0002182) regulation of cytoplasmic translational elongation(GO:1900247) negative regulation of cytoplasmic translational elongation(GO:1900248) |
| 0.7 |
4.0 |
GO:0030643 |
cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
| 0.6 |
1.3 |
GO:0072053 |
renal inner medulla development(GO:0072053) renal outer medulla development(GO:0072054) |
| 0.6 |
3.2 |
GO:0060838 |
lymphatic endothelial cell fate commitment(GO:0060838) regulation of transcription involved in lymphatic endothelial cell fate commitment(GO:0060849) |
| 0.6 |
3.8 |
GO:0015015 |
heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
| 0.6 |
5.6 |
GO:0071420 |
cellular response to histamine(GO:0071420) |
| 0.6 |
7.5 |
GO:0071286 |
cellular response to magnesium ion(GO:0071286) |
| 0.6 |
1.8 |
GO:0003221 |
right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
| 0.6 |
4.9 |
GO:0098903 |
regulation of membrane repolarization during action potential(GO:0098903) |
| 0.6 |
9.6 |
GO:0021902 |
commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
| 0.6 |
3.5 |
GO:0032483 |
regulation of Rab protein signal transduction(GO:0032483) |
| 0.6 |
4.1 |
GO:1901660 |
calcium ion export(GO:1901660) |
| 0.6 |
1.7 |
GO:0003349 |
epicardium-derived cardiac endothelial cell differentiation(GO:0003349) |
| 0.6 |
6.3 |
GO:0035970 |
peptidyl-threonine dephosphorylation(GO:0035970) |
| 0.6 |
3.4 |
GO:1903715 |
regulation of aerobic respiration(GO:1903715) |
| 0.6 |
3.4 |
GO:0000160 |
phosphorelay signal transduction system(GO:0000160) |
| 0.6 |
1.7 |
GO:2000852 |
regulation of corticosterone secretion(GO:2000852) |
| 0.5 |
6.0 |
GO:0071225 |
cellular response to muramyl dipeptide(GO:0071225) |
| 0.5 |
1.6 |
GO:0061303 |
cornea development in camera-type eye(GO:0061303) |
| 0.5 |
1.1 |
GO:0007412 |
axon target recognition(GO:0007412) |
| 0.5 |
0.5 |
GO:0042414 |
epinephrine metabolic process(GO:0042414) |
| 0.5 |
2.1 |
GO:0043974 |
histone H3-K27 acetylation(GO:0043974) regulation of histone H3-K27 acetylation(GO:1901674) |
| 0.5 |
2.1 |
GO:0021773 |
striatal medium spiny neuron differentiation(GO:0021773) |
| 0.5 |
1.1 |
GO:0002329 |
pre-B cell differentiation(GO:0002329) |
| 0.5 |
1.0 |
GO:2001245 |
regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
| 0.5 |
2.6 |
GO:0060158 |
phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
| 0.5 |
3.6 |
GO:0034047 |
regulation of protein phosphatase type 2A activity(GO:0034047) |
| 0.5 |
4.0 |
GO:0035507 |
regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
| 0.5 |
1.0 |
GO:0002031 |
G-protein coupled receptor internalization(GO:0002031) |
| 0.5 |
1.5 |
GO:1901250 |
regulation of lung goblet cell differentiation(GO:1901249) negative regulation of lung goblet cell differentiation(GO:1901250) |
| 0.5 |
1.5 |
GO:2001032 |
regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
| 0.5 |
2.0 |
GO:0019355 |
nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process(GO:0034627) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
| 0.5 |
2.0 |
GO:0021698 |
cerebellar cortex structural organization(GO:0021698) |
| 0.5 |
6.9 |
GO:1990403 |
embryonic brain development(GO:1990403) |
| 0.5 |
1.0 |
GO:1904529 |
regulation of actin filament binding(GO:1904529) regulation of actin binding(GO:1904616) |
| 0.5 |
1.9 |
GO:0006867 |
asparagine transport(GO:0006867) glutamine transport(GO:0006868) |
| 0.5 |
1.4 |
GO:0035864 |
response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
| 0.5 |
1.4 |
GO:2000616 |
negative regulation of histone H3-K9 acetylation(GO:2000616) |
| 0.5 |
4.7 |
GO:0021942 |
radial glia guided migration of Purkinje cell(GO:0021942) |
| 0.5 |
1.9 |
GO:0061010 |
gall bladder development(GO:0061010) |
| 0.5 |
1.9 |
GO:0042276 |
error-prone translesion synthesis(GO:0042276) |
| 0.5 |
1.4 |
GO:0002159 |
desmosome assembly(GO:0002159) |
| 0.5 |
9.6 |
GO:0016082 |
synaptic vesicle priming(GO:0016082) |
| 0.5 |
5.0 |
GO:0007221 |
positive regulation of transcription of Notch receptor target(GO:0007221) |
| 0.5 |
1.4 |
GO:0070212 |
protein poly-ADP-ribosylation(GO:0070212) |
| 0.5 |
0.9 |
GO:1902915 |
negative regulation of protein K63-linked ubiquitination(GO:1900045) negative regulation of protein polyubiquitination(GO:1902915) |
| 0.5 |
4.5 |
GO:0061470 |
T follicular helper cell differentiation(GO:0061470) |
| 0.5 |
0.9 |
GO:1902263 |
apoptotic process involved in embryonic digit morphogenesis(GO:1902263) |
| 0.4 |
1.3 |
GO:1900736 |
regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900736) |
| 0.4 |
3.6 |
GO:0048149 |
behavioral response to ethanol(GO:0048149) |
| 0.4 |
4.4 |
GO:0042118 |
endothelial cell activation(GO:0042118) |
| 0.4 |
4.4 |
GO:0000290 |
deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
| 0.4 |
1.7 |
GO:0072697 |
protein localization to cell cortex(GO:0072697) |
| 0.4 |
3.4 |
GO:0050882 |
voluntary musculoskeletal movement(GO:0050882) |
| 0.4 |
4.2 |
GO:0019227 |
neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
| 0.4 |
4.6 |
GO:0090394 |
negative regulation of excitatory postsynaptic potential(GO:0090394) |
| 0.4 |
1.6 |
GO:0018076 |
N-terminal peptidyl-lysine acetylation(GO:0018076) |
| 0.4 |
1.2 |
GO:0007290 |
spermatid nucleus elongation(GO:0007290) |
| 0.4 |
1.2 |
GO:0046880 |
regulation of follicle-stimulating hormone secretion(GO:0046880) follicle-stimulating hormone secretion(GO:0046884) |
| 0.4 |
1.2 |
GO:0036092 |
phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
| 0.4 |
0.8 |
GO:0045110 |
intermediate filament bundle assembly(GO:0045110) |
| 0.4 |
0.8 |
GO:0034310 |
primary alcohol catabolic process(GO:0034310) |
| 0.4 |
3.2 |
GO:0006265 |
DNA topological change(GO:0006265) |
| 0.4 |
1.6 |
GO:0033136 |
serine phosphorylation of STAT3 protein(GO:0033136) serine phosphorylation of STAT protein(GO:0042501) |
| 0.4 |
3.5 |
GO:0002318 |
myeloid progenitor cell differentiation(GO:0002318) |
| 0.4 |
3.5 |
GO:0032464 |
positive regulation of protein homooligomerization(GO:0032464) |
| 0.4 |
1.1 |
GO:2000620 |
positive regulation of histone H4-K16 acetylation(GO:2000620) |
| 0.4 |
1.1 |
GO:0034141 |
positive regulation of toll-like receptor 3 signaling pathway(GO:0034141) |
| 0.4 |
3.0 |
GO:0006620 |
posttranslational protein targeting to membrane(GO:0006620) |
| 0.4 |
3.0 |
GO:0046548 |
retinal rod cell development(GO:0046548) |
| 0.4 |
1.1 |
GO:1900149 |
positive regulation of Schwann cell migration(GO:1900149) |
| 0.4 |
1.5 |
GO:0071930 |
negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
| 0.4 |
1.5 |
GO:0036515 |
serotonergic neuron axon guidance(GO:0036515) |
| 0.4 |
1.5 |
GO:0032289 |
central nervous system myelin formation(GO:0032289) cardiac cell fate specification(GO:0060912) |
| 0.4 |
1.1 |
GO:0009405 |
pathogenesis(GO:0009405) |
| 0.4 |
1.1 |
GO:2000744 |
anterior head development(GO:0097065) regulation of anterior head development(GO:2000742) positive regulation of anterior head development(GO:2000744) |
| 0.4 |
1.5 |
GO:0072344 |
rescue of stalled ribosome(GO:0072344) |
| 0.4 |
1.5 |
GO:0046958 |
nonassociative learning(GO:0046958) |
| 0.3 |
2.1 |
GO:2000809 |
positive regulation of synaptic vesicle clustering(GO:2000809) |
| 0.3 |
1.7 |
GO:0070305 |
response to cGMP(GO:0070305) cellular response to cGMP(GO:0071321) |
| 0.3 |
4.2 |
GO:0035563 |
positive regulation of chromatin binding(GO:0035563) |
| 0.3 |
4.8 |
GO:0034770 |
histone H4-K20 methylation(GO:0034770) |
| 0.3 |
1.7 |
GO:0042780 |
tRNA 3'-end processing(GO:0042780) |
| 0.3 |
1.4 |
GO:0070562 |
regulation of vitamin D receptor signaling pathway(GO:0070562) |
| 0.3 |
2.0 |
GO:0090091 |
positive regulation of extracellular matrix disassembly(GO:0090091) |
| 0.3 |
1.0 |
GO:0007181 |
transforming growth factor beta receptor complex assembly(GO:0007181) |
| 0.3 |
0.7 |
GO:0014735 |
regulation of muscle atrophy(GO:0014735) |
| 0.3 |
1.7 |
GO:1900122 |
positive regulation of receptor binding(GO:1900122) |
| 0.3 |
1.7 |
GO:0090234 |
regulation of kinetochore assembly(GO:0090234) |
| 0.3 |
0.3 |
GO:0034140 |
negative regulation of toll-like receptor 3 signaling pathway(GO:0034140) |
| 0.3 |
1.0 |
GO:0032430 |
positive regulation of phospholipase A2 activity(GO:0032430) activation of meiosis involved in egg activation(GO:0060466) |
| 0.3 |
2.9 |
GO:0021684 |
cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
| 0.3 |
0.7 |
GO:0060024 |
rhythmic synaptic transmission(GO:0060024) |
| 0.3 |
2.6 |
GO:1902715 |
positive regulation of interferon-gamma secretion(GO:1902715) |
| 0.3 |
2.3 |
GO:0051534 |
negative regulation of NFAT protein import into nucleus(GO:0051534) |
| 0.3 |
1.0 |
GO:0070844 |
misfolded protein transport(GO:0070843) polyubiquitinated protein transport(GO:0070844) polyubiquitinated misfolded protein transport(GO:0070845) Hsp90 deacetylation(GO:0070846) |
| 0.3 |
2.9 |
GO:0035280 |
miRNA loading onto RISC involved in gene silencing by miRNA(GO:0035280) |
| 0.3 |
1.0 |
GO:0097309 |
cap1 mRNA methylation(GO:0097309) |
| 0.3 |
1.2 |
GO:0010499 |
proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
| 0.3 |
1.2 |
GO:0060715 |
syncytiotrophoblast cell differentiation involved in labyrinthine layer development(GO:0060715) |
| 0.3 |
1.9 |
GO:0072318 |
clathrin coat disassembly(GO:0072318) |
| 0.3 |
0.6 |
GO:0061343 |
cell adhesion involved in heart morphogenesis(GO:0061343) |
| 0.3 |
1.5 |
GO:0071415 |
cellular response to caffeine(GO:0071313) cellular response to purine-containing compound(GO:0071415) |
| 0.3 |
1.5 |
GO:0032485 |
regulation of Ral protein signal transduction(GO:0032485) |
| 0.3 |
2.1 |
GO:0017196 |
N-terminal peptidyl-methionine acetylation(GO:0017196) |
| 0.3 |
1.2 |
GO:0035616 |
histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
| 0.3 |
5.1 |
GO:0045116 |
protein neddylation(GO:0045116) |
| 0.3 |
0.3 |
GO:0006990 |
positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
| 0.3 |
2.0 |
GO:0060903 |
positive regulation of meiosis I(GO:0060903) |
| 0.3 |
2.6 |
GO:0035881 |
amacrine cell differentiation(GO:0035881) |
| 0.3 |
0.9 |
GO:0050915 |
sensory perception of sour taste(GO:0050915) |
| 0.3 |
2.6 |
GO:0044331 |
cell-cell adhesion mediated by cadherin(GO:0044331) |
| 0.3 |
10.3 |
GO:0021680 |
cerebellar Purkinje cell layer development(GO:0021680) |
| 0.3 |
0.6 |
GO:0070560 |
protein secretion by platelet(GO:0070560) |
| 0.3 |
3.1 |
GO:0021785 |
branchiomotor neuron axon guidance(GO:0021785) |
| 0.3 |
2.5 |
GO:0060013 |
righting reflex(GO:0060013) |
| 0.3 |
1.4 |
GO:2000774 |
positive regulation of cellular senescence(GO:2000774) |
| 0.3 |
0.8 |
GO:0090271 |
positive regulation of fibroblast growth factor production(GO:0090271) |
| 0.3 |
0.6 |
GO:0060693 |
regulation of branching involved in salivary gland morphogenesis(GO:0060693) |
| 0.3 |
1.4 |
GO:0032792 |
negative regulation of CREB transcription factor activity(GO:0032792) |
| 0.3 |
3.9 |
GO:0072010 |
renal filtration cell differentiation(GO:0061318) glomerular epithelium development(GO:0072010) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
| 0.3 |
9.6 |
GO:0061003 |
positive regulation of dendritic spine morphogenesis(GO:0061003) |
| 0.3 |
3.3 |
GO:0048172 |
regulation of short-term neuronal synaptic plasticity(GO:0048172) |
| 0.3 |
0.5 |
GO:0008626 |
granzyme-mediated apoptotic signaling pathway(GO:0008626) |
| 0.3 |
0.8 |
GO:0014043 |
negative regulation of neuron maturation(GO:0014043) |
| 0.3 |
0.8 |
GO:0006667 |
sphinganine metabolic process(GO:0006667) |
| 0.3 |
0.8 |
GO:0007621 |
negative regulation of female receptivity(GO:0007621) |
| 0.3 |
2.1 |
GO:0007252 |
I-kappaB phosphorylation(GO:0007252) |
| 0.3 |
0.3 |
GO:0003211 |
cardiac ventricle formation(GO:0003211) |
| 0.3 |
1.0 |
GO:0070425 |
negative regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070425) negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070433) |
| 0.3 |
1.3 |
GO:0097343 |
ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
| 0.3 |
0.8 |
GO:0007403 |
glial cell fate determination(GO:0007403) |
| 0.3 |
2.0 |
GO:0045647 |
negative regulation of erythrocyte differentiation(GO:0045647) |
| 0.3 |
2.5 |
GO:0032418 |
lysosome localization(GO:0032418) |
| 0.3 |
1.3 |
GO:0007195 |
adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
| 0.3 |
0.8 |
GO:0034241 |
positive regulation of macrophage fusion(GO:0034241) regulation of osteoclast proliferation(GO:0090289) |
| 0.3 |
1.3 |
GO:0016198 |
axon choice point recognition(GO:0016198) |
| 0.3 |
1.5 |
GO:0045072 |
regulation of interferon-gamma biosynthetic process(GO:0045072) positive regulation of interferon-gamma biosynthetic process(GO:0045078) |
| 0.2 |
2.0 |
GO:0045199 |
maintenance of epithelial cell apical/basal polarity(GO:0045199) |
| 0.2 |
1.2 |
GO:0001842 |
neural fold formation(GO:0001842) |
| 0.2 |
1.2 |
GO:0070100 |
negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
| 0.2 |
8.3 |
GO:2001222 |
regulation of neuron migration(GO:2001222) |
| 0.2 |
1.2 |
GO:0006543 |
glutamine catabolic process(GO:0006543) |
| 0.2 |
1.7 |
GO:0021796 |
cerebral cortex regionalization(GO:0021796) |
| 0.2 |
3.1 |
GO:0031987 |
locomotion involved in locomotory behavior(GO:0031987) |
| 0.2 |
2.4 |
GO:0090315 |
negative regulation of protein targeting to membrane(GO:0090315) |
| 0.2 |
2.1 |
GO:0007379 |
segment specification(GO:0007379) |
| 0.2 |
2.6 |
GO:0010839 |
negative regulation of keratinocyte proliferation(GO:0010839) |
| 0.2 |
1.6 |
GO:0007296 |
vitellogenesis(GO:0007296) |
| 0.2 |
0.7 |
GO:0015793 |
glycerol transport(GO:0015793) |
| 0.2 |
0.9 |
GO:0000415 |
negative regulation of histone H3-K36 methylation(GO:0000415) |
| 0.2 |
0.5 |
GO:0043950 |
positive regulation of cAMP-mediated signaling(GO:0043950) |
| 0.2 |
0.7 |
GO:0039536 |
negative regulation of RIG-I signaling pathway(GO:0039536) |
| 0.2 |
1.3 |
GO:0060017 |
parathyroid gland development(GO:0060017) |
| 0.2 |
0.9 |
GO:0031915 |
positive regulation of synaptic plasticity(GO:0031915) |
| 0.2 |
0.7 |
GO:0098528 |
skeletal muscle fiber differentiation(GO:0098528) |
| 0.2 |
0.9 |
GO:2000110 |
protein sialylation(GO:1990743) negative regulation of macrophage apoptotic process(GO:2000110) |
| 0.2 |
1.5 |
GO:0010825 |
positive regulation of centrosome duplication(GO:0010825) |
| 0.2 |
0.7 |
GO:0043988 |
histone H3-S28 phosphorylation(GO:0043988) |
| 0.2 |
0.4 |
GO:0060117 |
auditory receptor cell development(GO:0060117) |
| 0.2 |
1.1 |
GO:0045654 |
positive regulation of megakaryocyte differentiation(GO:0045654) |
| 0.2 |
1.1 |
GO:0097264 |
self proteolysis(GO:0097264) |
| 0.2 |
1.1 |
GO:0019236 |
response to pheromone(GO:0019236) |
| 0.2 |
1.3 |
GO:0072321 |
chaperone-mediated protein transport(GO:0072321) |
| 0.2 |
0.4 |
GO:0003192 |
mitral valve formation(GO:0003192) |
| 0.2 |
3.6 |
GO:0034643 |
establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
| 0.2 |
1.5 |
GO:0045924 |
regulation of female receptivity(GO:0045924) |
| 0.2 |
2.3 |
GO:0051481 |
negative regulation of cytosolic calcium ion concentration(GO:0051481) |
| 0.2 |
0.8 |
GO:0010891 |
negative regulation of sequestering of triglyceride(GO:0010891) |
| 0.2 |
1.9 |
GO:0030828 |
positive regulation of cGMP biosynthetic process(GO:0030828) |
| 0.2 |
1.0 |
GO:0072610 |
interleukin-12 secretion(GO:0072610) regulation of interleukin-12 secretion(GO:2001182) positive regulation of interleukin-12 secretion(GO:2001184) |
| 0.2 |
2.5 |
GO:0010832 |
negative regulation of myotube differentiation(GO:0010832) |
| 0.2 |
1.2 |
GO:0070314 |
G1 to G0 transition(GO:0070314) |
| 0.2 |
1.2 |
GO:0070863 |
positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
| 0.2 |
1.0 |
GO:0090168 |
Golgi reassembly(GO:0090168) |
| 0.2 |
0.8 |
GO:0055099 |
response to high density lipoprotein particle(GO:0055099) |
| 0.2 |
2.2 |
GO:1902259 |
regulation of delayed rectifier potassium channel activity(GO:1902259) |
| 0.2 |
0.6 |
GO:0006097 |
glyoxylate cycle(GO:0006097) |
| 0.2 |
0.2 |
GO:0045410 |
positive regulation of interleukin-6 biosynthetic process(GO:0045410) |
| 0.2 |
2.3 |
GO:0048672 |
positive regulation of collateral sprouting(GO:0048672) |
| 0.2 |
10.0 |
GO:0046513 |
ceramide biosynthetic process(GO:0046513) |
| 0.2 |
0.2 |
GO:0019732 |
antifungal humoral response(GO:0019732) |
| 0.2 |
1.0 |
GO:0018125 |
peptidyl-cysteine methylation(GO:0018125) |
| 0.2 |
0.4 |
GO:0070317 |
negative regulation of G0 to G1 transition(GO:0070317) |
| 0.2 |
0.8 |
GO:1901165 |
positive regulation of trophoblast cell migration(GO:1901165) |
| 0.2 |
0.4 |
GO:0014886 |
transition between slow and fast fiber(GO:0014886) |
| 0.2 |
1.3 |
GO:0071044 |
histone mRNA catabolic process(GO:0071044) |
| 0.2 |
4.9 |
GO:0046854 |
lipid phosphorylation(GO:0046834) phosphatidylinositol phosphorylation(GO:0046854) |
| 0.2 |
2.0 |
GO:0060124 |
positive regulation of growth hormone secretion(GO:0060124) |
| 0.2 |
0.7 |
GO:0055071 |
cellular manganese ion homeostasis(GO:0030026) Golgi calcium ion homeostasis(GO:0032468) manganese ion homeostasis(GO:0055071) |
| 0.2 |
1.8 |
GO:1901621 |
regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901620) negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
| 0.2 |
2.3 |
GO:0097688 |
AMPA glutamate receptor clustering(GO:0097113) glutamate receptor clustering(GO:0097688) |
| 0.2 |
0.7 |
GO:0030950 |
establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
| 0.2 |
1.1 |
GO:0045650 |
negative regulation of macrophage differentiation(GO:0045650) |
| 0.2 |
1.0 |
GO:0070102 |
interleukin-6-mediated signaling pathway(GO:0070102) |
| 0.2 |
0.9 |
GO:0032962 |
positive regulation of inositol trisphosphate biosynthetic process(GO:0032962) |
| 0.2 |
6.1 |
GO:0006890 |
retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
| 0.2 |
0.3 |
GO:0070375 |
ERK5 cascade(GO:0070375) |
| 0.2 |
0.8 |
GO:0021914 |
negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
| 0.2 |
0.7 |
GO:0046684 |
response to pyrethroid(GO:0046684) |
| 0.2 |
0.2 |
GO:0036451 |
cap mRNA methylation(GO:0036451) |
| 0.2 |
0.3 |
GO:0048162 |
preantral ovarian follicle growth(GO:0001546) multi-layer follicle stage(GO:0048162) |
| 0.2 |
3.0 |
GO:2000369 |
regulation of clathrin-mediated endocytosis(GO:2000369) |
| 0.2 |
1.0 |
GO:0044829 |
positive regulation by host of viral genome replication(GO:0044829) |
| 0.2 |
0.5 |
GO:0071544 |
diphosphoinositol polyphosphate metabolic process(GO:0071543) diphosphoinositol polyphosphate catabolic process(GO:0071544) |
| 0.2 |
5.3 |
GO:0007218 |
neuropeptide signaling pathway(GO:0007218) |
| 0.2 |
1.3 |
GO:0016338 |
calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
| 0.2 |
0.3 |
GO:2000664 |
positive regulation of interleukin-5 secretion(GO:2000664) positive regulation of interleukin-13 secretion(GO:2000667) |
| 0.2 |
1.8 |
GO:0031936 |
negative regulation of chromatin silencing(GO:0031936) |
| 0.2 |
1.3 |
GO:0007413 |
axonal fasciculation(GO:0007413) |
| 0.2 |
0.8 |
GO:0000056 |
ribosomal small subunit export from nucleus(GO:0000056) |
| 0.2 |
0.5 |
GO:0060075 |
regulation of resting membrane potential(GO:0060075) |
| 0.2 |
1.6 |
GO:0051382 |
kinetochore assembly(GO:0051382) |
| 0.2 |
0.9 |
GO:0055003 |
cardiac myofibril assembly(GO:0055003) |
| 0.2 |
0.6 |
GO:2000587 |
regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000586) negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
| 0.2 |
0.5 |
GO:0033169 |
histone H3-K9 demethylation(GO:0033169) |
| 0.2 |
0.5 |
GO:2000574 |
regulation of microtubule motor activity(GO:2000574) |
| 0.2 |
1.7 |
GO:0055090 |
acylglycerol homeostasis(GO:0055090) triglyceride homeostasis(GO:0070328) |
| 0.2 |
0.8 |
GO:0071894 |
histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
| 0.2 |
0.6 |
GO:0032484 |
Ral protein signal transduction(GO:0032484) |
| 0.2 |
0.8 |
GO:0045974 |
miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
| 0.2 |
0.9 |
GO:0032796 |
uropod organization(GO:0032796) early endosome to recycling endosome transport(GO:0061502) |
| 0.2 |
0.8 |
GO:0051012 |
microtubule sliding(GO:0051012) negative regulation of nonmotile primary cilium assembly(GO:1902856) |
| 0.2 |
0.5 |
GO:0048211 |
Golgi vesicle docking(GO:0048211) |
| 0.2 |
0.5 |
GO:0048208 |
vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) |
| 0.2 |
0.5 |
GO:1900126 |
negative regulation of hyaluronan biosynthetic process(GO:1900126) |
| 0.1 |
0.6 |
GO:0010459 |
negative regulation of heart rate(GO:0010459) |
| 0.1 |
0.9 |
GO:0061718 |
NADH regeneration(GO:0006735) canonical glycolysis(GO:0061621) glucose catabolic process to pyruvate(GO:0061718) |
| 0.1 |
0.4 |
GO:0016553 |
adenosine to inosine editing(GO:0006382) base conversion or substitution editing(GO:0016553) |
| 0.1 |
0.3 |
GO:0060392 |
negative regulation of SMAD protein import into nucleus(GO:0060392) |
| 0.1 |
0.6 |
GO:0050435 |
beta-amyloid metabolic process(GO:0050435) |
| 0.1 |
1.0 |
GO:0090306 |
spindle assembly involved in meiosis(GO:0090306) |
| 0.1 |
1.3 |
GO:2000052 |
positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
| 0.1 |
0.7 |
GO:2000348 |
regulation of CD40 signaling pathway(GO:2000348) |
| 0.1 |
1.1 |
GO:0071157 |
negative regulation of cell cycle arrest(GO:0071157) |
| 0.1 |
1.0 |
GO:0031000 |
response to caffeine(GO:0031000) |
| 0.1 |
0.5 |
GO:0061157 |
mRNA destabilization(GO:0061157) |
| 0.1 |
0.1 |
GO:0021559 |
trigeminal nerve development(GO:0021559) |
| 0.1 |
0.8 |
GO:0033147 |
negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
| 0.1 |
0.4 |
GO:0070086 |
ubiquitin-dependent endocytosis(GO:0070086) |
| 0.1 |
0.5 |
GO:0045932 |
negative regulation of muscle contraction(GO:0045932) |
| 0.1 |
0.7 |
GO:0035520 |
monoubiquitinated protein deubiquitination(GO:0035520) |
| 0.1 |
0.4 |
GO:0071169 |
establishment of protein localization to chromatin(GO:0071169) |
| 0.1 |
0.8 |
GO:0010747 |
positive regulation of plasma membrane long-chain fatty acid transport(GO:0010747) |
| 0.1 |
0.8 |
GO:0071699 |
olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
| 0.1 |
1.9 |
GO:0071625 |
vocalization behavior(GO:0071625) |
| 0.1 |
2.1 |
GO:0035024 |
negative regulation of Rho protein signal transduction(GO:0035024) |
| 0.1 |
0.6 |
GO:1900095 |
regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
| 0.1 |
0.7 |
GO:0006177 |
GMP biosynthetic process(GO:0006177) |
| 0.1 |
0.1 |
GO:1901536 |
regulation of DNA demethylation(GO:1901535) negative regulation of DNA demethylation(GO:1901536) |
| 0.1 |
1.2 |
GO:0060314 |
regulation of ryanodine-sensitive calcium-release channel activity(GO:0060314) |
| 0.1 |
0.3 |
GO:1903215 |
negative regulation of protein targeting to mitochondrion(GO:1903215) |
| 0.1 |
1.0 |
GO:0000183 |
chromatin silencing at rDNA(GO:0000183) |
| 0.1 |
0.7 |
GO:0050957 |
equilibrioception(GO:0050957) |
| 0.1 |
2.5 |
GO:1901385 |
regulation of voltage-gated calcium channel activity(GO:1901385) |
| 0.1 |
0.3 |
GO:0086046 |
membrane depolarization during SA node cell action potential(GO:0086046) |
| 0.1 |
0.2 |
GO:0060025 |
regulation of synaptic activity(GO:0060025) |
| 0.1 |
2.4 |
GO:0010738 |
regulation of protein kinase A signaling(GO:0010738) |
| 0.1 |
0.2 |
GO:0010730 |
negative regulation of hydrogen peroxide metabolic process(GO:0010727) negative regulation of hydrogen peroxide biosynthetic process(GO:0010730) |
| 0.1 |
0.2 |
GO:0034729 |
histone H3-K79 methylation(GO:0034729) |
| 0.1 |
2.9 |
GO:0016578 |
histone deubiquitination(GO:0016578) |
| 0.1 |
1.5 |
GO:0048148 |
behavioral response to cocaine(GO:0048148) |
| 0.1 |
0.5 |
GO:0051013 |
microtubule severing(GO:0051013) |
| 0.1 |
1.8 |
GO:0031297 |
replication fork processing(GO:0031297) |
| 0.1 |
0.5 |
GO:0060766 |
negative regulation of androgen receptor signaling pathway(GO:0060766) |
| 0.1 |
1.2 |
GO:0007214 |
gamma-aminobutyric acid signaling pathway(GO:0007214) |
| 0.1 |
0.5 |
GO:0021592 |
fourth ventricle development(GO:0021592) initiation of neural tube closure(GO:0021993) |
| 0.1 |
0.8 |
GO:0060213 |
regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060211) positive regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060213) |
| 0.1 |
0.3 |
GO:0010636 |
positive regulation of mitochondrial fusion(GO:0010636) |
| 0.1 |
0.5 |
GO:0072643 |
interferon-gamma secretion(GO:0072643) |
| 0.1 |
0.6 |
GO:0071361 |
cellular response to ethanol(GO:0071361) |
| 0.1 |
2.3 |
GO:0031061 |
negative regulation of histone methylation(GO:0031061) |
| 0.1 |
0.7 |
GO:0044387 |
negative regulation of protein kinase activity by regulation of protein phosphorylation(GO:0044387) |
| 0.1 |
1.6 |
GO:0035518 |
histone H2A monoubiquitination(GO:0035518) |
| 0.1 |
4.4 |
GO:0006513 |
protein monoubiquitination(GO:0006513) |
| 0.1 |
3.0 |
GO:1902668 |
negative regulation of axon extension involved in axon guidance(GO:0048843) negative regulation of axon guidance(GO:1902668) |
| 0.1 |
0.3 |
GO:0006012 |
galactose metabolic process(GO:0006012) |
| 0.1 |
0.1 |
GO:0010886 |
positive regulation of cholesterol storage(GO:0010886) |
| 0.1 |
0.6 |
GO:0035469 |
determination of pancreatic left/right asymmetry(GO:0035469) determination of liver left/right asymmetry(GO:0071910) |
| 0.1 |
0.2 |
GO:0002724 |
regulation of T cell cytokine production(GO:0002724) |
| 0.1 |
0.8 |
GO:0051764 |
actin crosslink formation(GO:0051764) |
| 0.1 |
2.1 |
GO:0048488 |
synaptic vesicle endocytosis(GO:0048488) |
| 0.1 |
0.8 |
GO:0010603 |
regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
| 0.1 |
1.3 |
GO:1903861 |
regulation of dendrite extension(GO:1903859) positive regulation of dendrite extension(GO:1903861) |
| 0.1 |
0.5 |
GO:0070234 |
positive regulation of T cell apoptotic process(GO:0070234) |
| 0.1 |
1.3 |
GO:0006857 |
oligopeptide transport(GO:0006857) |
| 0.1 |
0.3 |
GO:0031440 |
regulation of mRNA 3'-end processing(GO:0031440) |
| 0.1 |
0.3 |
GO:0070544 |
histone H3-K36 demethylation(GO:0070544) |
| 0.1 |
0.3 |
GO:1903599 |
positive regulation of mitophagy(GO:1903599) |
| 0.1 |
1.0 |
GO:2000310 |
regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
| 0.1 |
1.2 |
GO:0061469 |
regulation of type B pancreatic cell proliferation(GO:0061469) |
| 0.1 |
0.6 |
GO:0006957 |
complement activation, alternative pathway(GO:0006957) |
| 0.1 |
0.3 |
GO:0003025 |
regulation of systemic arterial blood pressure by baroreceptor feedback(GO:0003025) glossopharyngeal nerve development(GO:0021563) vagus nerve development(GO:0021564) |
| 0.1 |
0.1 |
GO:0060591 |
chondroblast differentiation(GO:0060591) |
| 0.1 |
0.5 |
GO:0030579 |
ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
| 0.1 |
2.5 |
GO:0000002 |
mitochondrial genome maintenance(GO:0000002) |
| 0.1 |
1.4 |
GO:0002495 |
antigen processing and presentation of peptide antigen via MHC class II(GO:0002495) |
| 0.1 |
0.8 |
GO:0001960 |
negative regulation of cytokine-mediated signaling pathway(GO:0001960) |
| 0.1 |
0.6 |
GO:0001771 |
immunological synapse formation(GO:0001771) |
| 0.1 |
1.2 |
GO:0001553 |
luteinization(GO:0001553) |
| 0.1 |
0.3 |
GO:0032875 |
regulation of DNA endoreduplication(GO:0032875) DNA endoreduplication(GO:0042023) |
| 0.1 |
0.8 |
GO:0032959 |
inositol trisphosphate biosynthetic process(GO:0032959) |
| 0.1 |
1.0 |
GO:0060065 |
uterus development(GO:0060065) |
| 0.1 |
0.4 |
GO:0006780 |
uroporphyrinogen III biosynthetic process(GO:0006780) |
| 0.1 |
2.1 |
GO:0043666 |
regulation of phosphoprotein phosphatase activity(GO:0043666) |
| 0.1 |
0.3 |
GO:0002457 |
T cell antigen processing and presentation(GO:0002457) |
| 0.1 |
0.6 |
GO:0086012 |
membrane depolarization during cardiac muscle cell action potential(GO:0086012) |
| 0.1 |
1.9 |
GO:0060749 |
mammary gland alveolus development(GO:0060749) mammary gland lobule development(GO:0061377) |
| 0.1 |
0.6 |
GO:0070933 |
histone H4 deacetylation(GO:0070933) |
| 0.1 |
0.8 |
GO:0032703 |
negative regulation of interleukin-2 production(GO:0032703) |
| 0.1 |
0.9 |
GO:1901409 |
regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
| 0.1 |
0.3 |
GO:0090399 |
replicative senescence(GO:0090399) |
| 0.1 |
1.4 |
GO:1900745 |
positive regulation of p38MAPK cascade(GO:1900745) |
| 0.1 |
1.2 |
GO:0032148 |
activation of protein kinase B activity(GO:0032148) |
| 0.1 |
1.7 |
GO:0061099 |
negative regulation of protein tyrosine kinase activity(GO:0061099) |
| 0.1 |
0.6 |
GO:0006390 |
transcription from mitochondrial promoter(GO:0006390) |
| 0.1 |
0.2 |
GO:0040009 |
regulation of growth rate(GO:0040009) |
| 0.1 |
0.7 |
GO:0097576 |
autophagosome maturation(GO:0097352) vacuole fusion(GO:0097576) |
| 0.1 |
0.7 |
GO:0098532 |
histone H3-K27 trimethylation(GO:0098532) |
| 0.1 |
0.9 |
GO:0019243 |
methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
| 0.1 |
11.3 |
GO:0042787 |
protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0042787) |
| 0.1 |
0.5 |
GO:0071380 |
cellular response to prostaglandin stimulus(GO:0071379) cellular response to prostaglandin E stimulus(GO:0071380) |
| 0.1 |
0.7 |
GO:0021979 |
hypothalamus cell differentiation(GO:0021979) |
| 0.1 |
0.8 |
GO:0043923 |
positive regulation by host of viral transcription(GO:0043923) |
| 0.1 |
0.3 |
GO:1904690 |
regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
| 0.1 |
0.4 |
GO:0014029 |
neural crest formation(GO:0014029) |
| 0.1 |
0.3 |
GO:0042256 |
mature ribosome assembly(GO:0042256) |
| 0.1 |
0.3 |
GO:0046543 |
development of secondary female sexual characteristics(GO:0046543) |
| 0.1 |
0.3 |
GO:0098543 |
detection of bacterium(GO:0016045) detection of other organism(GO:0098543) |
| 0.1 |
1.6 |
GO:0046580 |
negative regulation of Ras protein signal transduction(GO:0046580) negative regulation of small GTPase mediated signal transduction(GO:0051058) |
| 0.1 |
0.2 |
GO:0006556 |
S-adenosylmethionine biosynthetic process(GO:0006556) |
| 0.1 |
0.1 |
GO:0051532 |
regulation of NFAT protein import into nucleus(GO:0051532) |
| 0.1 |
1.0 |
GO:0051127 |
positive regulation of actin nucleation(GO:0051127) |
| 0.1 |
1.6 |
GO:0000413 |
protein peptidyl-prolyl isomerization(GO:0000413) |
| 0.1 |
0.8 |
GO:0048280 |
vesicle fusion with Golgi apparatus(GO:0048280) |
| 0.1 |
0.1 |
GO:0060743 |
prostate gland stromal morphogenesis(GO:0060741) epithelial cell maturation involved in prostate gland development(GO:0060743) |
| 0.1 |
0.1 |
GO:2000821 |
regulation of grooming behavior(GO:2000821) |
| 0.1 |
0.4 |
GO:0048011 |
neurotrophin TRK receptor signaling pathway(GO:0048011) |
| 0.1 |
0.3 |
GO:0030263 |
apoptotic chromosome condensation(GO:0030263) |
| 0.1 |
0.1 |
GO:0000087 |
mitotic M phase(GO:0000087) mitotic cell cycle phase(GO:0098763) |
| 0.1 |
1.3 |
GO:0019884 |
antigen processing and presentation of exogenous antigen(GO:0019884) |
| 0.1 |
3.3 |
GO:0051965 |
positive regulation of synapse assembly(GO:0051965) |
| 0.1 |
0.6 |
GO:0060159 |
regulation of dopamine receptor signaling pathway(GO:0060159) |
| 0.1 |
0.3 |
GO:0007603 |
phototransduction, visible light(GO:0007603) |
| 0.1 |
0.6 |
GO:0034551 |
respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
| 0.1 |
0.2 |
GO:0015910 |
peroxisomal long-chain fatty acid import(GO:0015910) |
| 0.1 |
0.6 |
GO:0060052 |
neurofilament cytoskeleton organization(GO:0060052) |
| 0.1 |
0.9 |
GO:0090140 |
regulation of mitochondrial fission(GO:0090140) |
| 0.1 |
0.3 |
GO:0048102 |
autophagic cell death(GO:0048102) |
| 0.1 |
0.4 |
GO:0000022 |
mitotic spindle elongation(GO:0000022) mitotic spindle midzone assembly(GO:0051256) |
| 0.1 |
1.3 |
GO:0045722 |
positive regulation of gluconeogenesis(GO:0045722) |
| 0.1 |
0.9 |
GO:0008088 |
axo-dendritic transport(GO:0008088) |
| 0.1 |
0.6 |
GO:2000352 |
negative regulation of endothelial cell apoptotic process(GO:2000352) |
| 0.1 |
0.3 |
GO:0070076 |
histone lysine demethylation(GO:0070076) |
| 0.1 |
0.3 |
GO:2000189 |
positive regulation of cholesterol homeostasis(GO:2000189) |
| 0.1 |
0.3 |
GO:0009052 |
pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
| 0.1 |
1.2 |
GO:0007020 |
microtubule nucleation(GO:0007020) |
| 0.1 |
0.9 |
GO:0010800 |
positive regulation of peptidyl-threonine phosphorylation(GO:0010800) |
| 0.1 |
0.3 |
GO:0042760 |
very long-chain fatty acid catabolic process(GO:0042760) |
| 0.1 |
0.5 |
GO:0048255 |
mRNA stabilization(GO:0048255) |
| 0.1 |
1.9 |
GO:0061512 |
protein localization to cilium(GO:0061512) |
| 0.1 |
0.6 |
GO:0009072 |
aromatic amino acid family metabolic process(GO:0009072) |
| 0.1 |
0.7 |
GO:0071156 |
regulation of cell cycle arrest(GO:0071156) |
| 0.1 |
0.3 |
GO:1903056 |
mammillary body development(GO:0021767) mammillary axonal complex development(GO:0061373) melanocyte migration(GO:0097324) regulation of lens fiber cell differentiation(GO:1902746) positive regulation of lens fiber cell differentiation(GO:1902748) regulation of melanosome organization(GO:1903056) |
| 0.1 |
0.2 |
GO:0060447 |
bud outgrowth involved in lung branching(GO:0060447) |
| 0.1 |
0.8 |
GO:1900037 |
regulation of cellular response to hypoxia(GO:1900037) |
| 0.1 |
0.2 |
GO:0072092 |
ureteric bud invasion(GO:0072092) |
| 0.1 |
0.5 |
GO:0006968 |
cellular defense response(GO:0006968) |
| 0.1 |
0.1 |
GO:0008298 |
intracellular mRNA localization(GO:0008298) |
| 0.1 |
0.2 |
GO:1901475 |
pyruvate transmembrane transport(GO:1901475) |
| 0.1 |
0.2 |
GO:0048254 |
snoRNA localization(GO:0048254) |
| 0.1 |
1.2 |
GO:0034243 |
regulation of transcription elongation from RNA polymerase II promoter(GO:0034243) |
| 0.1 |
0.6 |
GO:0046716 |
muscle cell cellular homeostasis(GO:0046716) |
| 0.1 |
0.6 |
GO:0043984 |
histone H4-K16 acetylation(GO:0043984) |
| 0.1 |
0.7 |
GO:0090280 |
positive regulation of calcium ion import(GO:0090280) |
| 0.1 |
0.4 |
GO:0031293 |
membrane protein intracellular domain proteolysis(GO:0031293) |
| 0.0 |
0.5 |
GO:0006610 |
ribosomal protein import into nucleus(GO:0006610) |
| 0.0 |
0.3 |
GO:0051823 |
regulation of synapse structural plasticity(GO:0051823) |
| 0.0 |
1.9 |
GO:0072384 |
organelle transport along microtubule(GO:0072384) |
| 0.0 |
0.1 |
GO:0090209 |
negative regulation of triglyceride metabolic process(GO:0090209) |
| 0.0 |
0.3 |
GO:0070816 |
phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
| 0.0 |
0.3 |
GO:0006995 |
cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
| 0.0 |
0.4 |
GO:0043162 |
ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
| 0.0 |
0.1 |
GO:0048227 |
plasma membrane to endosome transport(GO:0048227) |
| 0.0 |
0.2 |
GO:0051725 |
protein de-ADP-ribosylation(GO:0051725) |
| 0.0 |
0.5 |
GO:0044872 |
lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
| 0.0 |
0.2 |
GO:1901642 |
purine nucleoside transmembrane transport(GO:0015860) purine-containing compound transmembrane transport(GO:0072530) nucleoside transmembrane transport(GO:1901642) nucleotide transmembrane transport(GO:1901679) |
| 0.0 |
0.6 |
GO:0045947 |
negative regulation of translational initiation(GO:0045947) |
| 0.0 |
0.1 |
GO:0030011 |
maintenance of cell polarity(GO:0030011) |
| 0.0 |
0.1 |
GO:0080009 |
mRNA methylation(GO:0080009) |
| 0.0 |
0.4 |
GO:1904262 |
negative regulation of TORC1 signaling(GO:1904262) |
| 0.0 |
0.1 |
GO:0043353 |
enucleate erythrocyte differentiation(GO:0043353) |
| 0.0 |
0.1 |
GO:0019074 |
viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
| 0.0 |
0.2 |
GO:0000395 |
mRNA 5'-splice site recognition(GO:0000395) |
| 0.0 |
0.7 |
GO:0043248 |
proteasome assembly(GO:0043248) |
| 0.0 |
3.8 |
GO:0007018 |
microtubule-based movement(GO:0007018) |
| 0.0 |
5.3 |
GO:0043484 |
regulation of RNA splicing(GO:0043484) |
| 0.0 |
0.3 |
GO:0015074 |
DNA integration(GO:0015074) |
| 0.0 |
0.6 |
GO:0048240 |
sperm capacitation(GO:0048240) |
| 0.0 |
0.2 |
GO:0044804 |
nucleophagy(GO:0044804) |
| 0.0 |
0.2 |
GO:0070327 |
thyroid hormone transport(GO:0070327) |
| 0.0 |
1.3 |
GO:0008333 |
endosome to lysosome transport(GO:0008333) |
| 0.0 |
0.2 |
GO:0010803 |
regulation of tumor necrosis factor-mediated signaling pathway(GO:0010803) |
| 0.0 |
0.3 |
GO:0031508 |
pericentric heterochromatin assembly(GO:0031508) |
| 0.0 |
0.3 |
GO:0051482 |
positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway(GO:0051482) |
| 0.0 |
0.4 |
GO:0002224 |
toll-like receptor signaling pathway(GO:0002224) |
| 0.0 |
0.6 |
GO:0045104 |
intermediate filament cytoskeleton organization(GO:0045104) |
| 0.0 |
0.5 |
GO:0009191 |
ribonucleoside diphosphate catabolic process(GO:0009191) |
| 0.0 |
1.6 |
GO:0008156 |
negative regulation of DNA replication(GO:0008156) |
| 0.0 |
0.3 |
GO:0098907 |
regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion(GO:0010881) protein localization to M-band(GO:0036309) protein localization to T-tubule(GO:0036371) regulation of SA node cell action potential(GO:0098907) |
| 0.0 |
0.1 |
GO:0046210 |
nitrate catabolic process(GO:0043602) nitric oxide catabolic process(GO:0046210) cellular organohalogen metabolic process(GO:0090345) cellular organofluorine metabolic process(GO:0090346) |
| 0.0 |
0.1 |
GO:1903237 |
negative regulation of leukocyte tethering or rolling(GO:1903237) |
| 0.0 |
2.9 |
GO:0051297 |
centrosome organization(GO:0051297) |
| 0.0 |
0.1 |
GO:0009584 |
detection of visible light(GO:0009584) |
| 0.0 |
2.3 |
GO:0090630 |
activation of GTPase activity(GO:0090630) |
| 0.0 |
0.1 |
GO:0000350 |
generation of catalytic spliceosome for second transesterification step(GO:0000350) |
| 0.0 |
1.9 |
GO:0008344 |
adult locomotory behavior(GO:0008344) |
| 0.0 |
0.2 |
GO:2000491 |
positive regulation of hepatic stellate cell activation(GO:2000491) |
| 0.0 |
0.2 |
GO:0050687 |
negative regulation of defense response to virus(GO:0050687) |
| 0.0 |
1.0 |
GO:0032728 |
positive regulation of interferon-beta production(GO:0032728) |
| 0.0 |
0.6 |
GO:0044088 |
regulation of vacuole organization(GO:0044088) |
| 0.0 |
0.2 |
GO:0007197 |
adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
| 0.0 |
0.2 |
GO:0000083 |
regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
| 0.0 |
0.4 |
GO:0045792 |
negative regulation of cell size(GO:0045792) |
| 0.0 |
0.1 |
GO:0043985 |
histone H4-R3 methylation(GO:0043985) |
| 0.0 |
0.1 |
GO:0031645 |
negative regulation of myelination(GO:0031642) negative regulation of neurological system process(GO:0031645) |
| 0.0 |
0.1 |
GO:2000172 |
regulation of branching morphogenesis of a nerve(GO:2000172) |
| 0.0 |
0.3 |
GO:2001241 |
positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
| 0.0 |
0.2 |
GO:0018026 |
peptidyl-lysine monomethylation(GO:0018026) |
| 0.0 |
0.2 |
GO:0097369 |
sodium ion import(GO:0097369) sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
| 0.0 |
0.1 |
GO:0045200 |
establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
| 0.0 |
1.2 |
GO:0006497 |
protein lipidation(GO:0006497) |
| 0.0 |
0.1 |
GO:0045578 |
negative regulation of B cell differentiation(GO:0045578) |
| 0.0 |
0.1 |
GO:0050910 |
detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
| 0.0 |
0.3 |
GO:0030521 |
androgen receptor signaling pathway(GO:0030521) |
| 0.0 |
0.4 |
GO:0016239 |
positive regulation of macroautophagy(GO:0016239) positive regulation of response to extracellular stimulus(GO:0032106) positive regulation of response to nutrient levels(GO:0032109) |
| 0.0 |
0.4 |
GO:0016973 |
poly(A)+ mRNA export from nucleus(GO:0016973) |
| 0.0 |
0.3 |
GO:0050892 |
intestinal absorption(GO:0050892) |
| 0.0 |
0.9 |
GO:0043967 |
histone H4 acetylation(GO:0043967) |
| 0.0 |
0.1 |
GO:0016556 |
mRNA modification(GO:0016556) |
| 0.0 |
0.1 |
GO:0090666 |
scaRNA localization to Cajal body(GO:0090666) |
| 0.0 |
0.2 |
GO:0051601 |
exocyst localization(GO:0051601) |
| 0.0 |
0.4 |
GO:0006308 |
DNA catabolic process(GO:0006308) |
| 0.0 |
0.2 |
GO:0045217 |
cell-cell junction maintenance(GO:0045217) |
| 0.0 |
0.1 |
GO:0014807 |
regulation of somitogenesis(GO:0014807) |
| 0.0 |
0.1 |
GO:0007202 |
activation of phospholipase C activity(GO:0007202) |
| 0.0 |
0.1 |
GO:0046007 |
negative regulation of activated T cell proliferation(GO:0046007) |
| 0.0 |
0.0 |
GO:2001137 |
positive regulation of endocytic recycling(GO:2001137) |
| 0.0 |
1.4 |
GO:0001578 |
microtubule bundle formation(GO:0001578) |
| 0.0 |
0.1 |
GO:0006438 |
valyl-tRNA aminoacylation(GO:0006438) |
| 0.0 |
1.2 |
GO:0010923 |
negative regulation of phosphatase activity(GO:0010923) |
| 0.0 |
0.1 |
GO:0046501 |
protoporphyrinogen IX metabolic process(GO:0046501) |
| 0.0 |
1.2 |
GO:0006096 |
glycolytic process(GO:0006096) ATP generation from ADP(GO:0006757) |
| 0.0 |
0.2 |
GO:0006544 |
glycine metabolic process(GO:0006544) |
| 0.0 |
0.4 |
GO:0030032 |
lamellipodium assembly(GO:0030032) |
| 0.0 |
0.6 |
GO:0048013 |
ephrin receptor signaling pathway(GO:0048013) |
| 0.0 |
1.0 |
GO:0032204 |
regulation of telomere maintenance(GO:0032204) |
| 0.0 |
0.2 |
GO:0019368 |
fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
| 0.0 |
0.1 |
GO:0071472 |
cellular response to salt stress(GO:0071472) |
| 0.0 |
0.1 |
GO:0046339 |
diacylglycerol metabolic process(GO:0046339) |
| 0.0 |
0.2 |
GO:0071028 |
nuclear RNA surveillance(GO:0071027) nuclear mRNA surveillance(GO:0071028) |
| 0.0 |
0.2 |
GO:0060546 |
negative regulation of necroptotic process(GO:0060546) |
| 0.0 |
0.0 |
GO:0046726 |
positive regulation by virus of viral protein levels in host cell(GO:0046726) |
| 0.0 |
0.1 |
GO:0048199 |
vesicle targeting, to, from or within Golgi(GO:0048199) |
| 0.0 |
0.3 |
GO:0072673 |
lamellipodium morphogenesis(GO:0072673) |
| 0.0 |
0.5 |
GO:1902476 |
chloride transmembrane transport(GO:1902476) |
| 0.0 |
0.1 |
GO:0035871 |
protein K11-linked deubiquitination(GO:0035871) |
| 0.0 |
0.3 |
GO:0000266 |
mitochondrial fission(GO:0000266) |
| 0.0 |
0.3 |
GO:0009083 |
branched-chain amino acid catabolic process(GO:0009083) |
| 0.0 |
0.3 |
GO:0032465 |
regulation of cytokinesis(GO:0032465) |
| 0.0 |
0.1 |
GO:0030449 |
regulation of complement activation(GO:0030449) negative regulation of complement activation(GO:0045916) regulation of protein activation cascade(GO:2000257) negative regulation of protein activation cascade(GO:2000258) |
| 0.0 |
0.1 |
GO:1900225 |
NLRP3 inflammasome complex assembly(GO:0044546) regulation of NLRP3 inflammasome complex assembly(GO:1900225) |
| 0.0 |
0.2 |
GO:0070536 |
protein K63-linked deubiquitination(GO:0070536) |
| 0.0 |
0.2 |
GO:0007638 |
mechanosensory behavior(GO:0007638) |
| 0.0 |
0.8 |
GO:0009247 |
glycolipid biosynthetic process(GO:0009247) |
| 0.0 |
1.6 |
GO:0006813 |
potassium ion transport(GO:0006813) |
| 0.0 |
0.2 |
GO:0046069 |
cGMP catabolic process(GO:0046069) |
| 0.0 |
0.1 |
GO:0003334 |
keratinocyte development(GO:0003334) |
| 0.0 |
0.1 |
GO:0016266 |
O-glycan processing(GO:0016266) |
| 0.0 |
0.1 |
GO:0045583 |
regulation of cytotoxic T cell differentiation(GO:0045583) positive regulation of cytotoxic T cell differentiation(GO:0045585) |
| 0.0 |
0.2 |
GO:0030866 |
cortical actin cytoskeleton organization(GO:0030866) |
| 0.0 |
0.1 |
GO:0017183 |
peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
| 0.0 |
0.2 |
GO:0010591 |
regulation of lamellipodium assembly(GO:0010591) |
| 0.0 |
0.2 |
GO:0010960 |
magnesium ion homeostasis(GO:0010960) |
| 0.0 |
0.1 |
GO:0071880 |
adenylate cyclase-activating adrenergic receptor signaling pathway(GO:0071880) |
| 0.0 |
0.3 |
GO:0015991 |
energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
| 0.0 |
0.3 |
GO:0003333 |
amino acid transmembrane transport(GO:0003333) |
| 0.0 |
0.3 |
GO:0006940 |
regulation of smooth muscle contraction(GO:0006940) |
| 0.0 |
0.2 |
GO:0048247 |
lymphocyte chemotaxis(GO:0048247) |
| 0.0 |
0.1 |
GO:0006370 |
7-methylguanosine mRNA capping(GO:0006370) |
| 0.0 |
0.0 |
GO:0070932 |
histone H3 deacetylation(GO:0070932) |
| 0.0 |
0.0 |
GO:0006983 |
ER overload response(GO:0006983) |
| 0.0 |
0.2 |
GO:0002474 |
antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
| 0.0 |
0.0 |
GO:0060689 |
cell differentiation involved in salivary gland development(GO:0060689) |
